Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Adamis Pharmaceuticals

Adamis Pharmaceuticals reported $7.88M in Operating Expenses for its fiscal quarter ending in March of 2023.

Operating Expenses Change
Adamis Pharmaceuticals ADMP:US USD 7.88M 1.9M
Adma Biologics ADMA:US USD 17.33M 38.71M
Brainstorm Cell Therapeutics BCLI:US USD 5.15M 236K
Cara Therapeutics CARA:US USD 33.82M 753K
GlaxoSmithKline GSK:LN GBP 4.87B 640M
Glaxosmithkline GSK:US GBP 4.87B 640M
Merck & Co MRK:US USD 10.76B 371M
Pfizer PFE:US USD 11.5B 7.63B
RedHill Biopharma RDHL:US USD 22.75M 1.91M